Peng Luo (Luo Peng)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 91

Top Topics

Small Cell Lung Cancer

Top Venues

Journal of translational medicine

Briefings in bioinformatics

Cell proliferation

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Yang, Xinyi Zhou, Jianbo Fang, Anqi Lin, Hongman Zhang, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan-cancer. Cancer science (2024)
Qi Yang, Xinyi Zhou, Jianbo Fang, Anqi Lin, Hongman Zhang, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan-cancer. Cancer science 115 (6) (2024)
Lingxuan Zhu, Weiming Mou, Yancheng Lai, Junda Lin, Peng Luo
Language and cultural bias in AI: comparing the performance of large language models developed in different countries on Traditional Chinese Medicine highlights the need for localized models. Journal of translational medicine 22 (1) (2024)
Lihaoyun Huang, Haitao Li, Cangang Zhang, Quan Chen, Zaoqu Liu, Jian Zhang, Peng Luo, Ting Wei
Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity. Clinical and translational medicine 14 (3) (2024)
Lingxuan Zhu, Weiming Mou, Chenglin Hong, Tao Yang, Yancheng Lai, Chang Qi, Anqi Lin, Jian Zhang, Peng Luo
The Evaluation of Generative AI Should Include Repetition to Assess Stability. JMIR mHealth and uHealth 12 (2024)
Ronghui Liang, Zi-Wei Ye, Zhenzhi Qin, Yubin Xie, Xiaomeng Yang, Haoran Sun, Qiaohui Du, Peng Luo, Kaiming Tang, Bodan Hu, Jianli Cao, Xavier Hoi-Leong Wong, Guang-Sheng Ling, Hin Chu, Jiangang Shen, Feifei Yin, Dong-Yan Jin, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, Shuo-Feng Yuan
PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness. Nature communications 15 (1) (2024)
Yu Li, Cangang Zhang, Aimin Jiang, Anqi Lin, Zaoqu Liu, Xiangshu Cheng, Wanting Wang, Quan Cheng, Jian Zhang, Ting Wei, Peng Luo
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review. Journal of translational medicine 22 (1) (2024)
Lingxuan Zhu, Weiming Mou, Keren Wu, Yancheng Lai, Anqi Lin, Tao Yang, Jian Zhang, Peng Luo
Multimodal ChatGPT-4V for Electrocardiogram Interpretation: Promise and Limitations. Journal of medical Internet research 26 (2024)
Lingxuan Zhu, Weiming Mou, Keren Wu, Yancheng Lai, Anqi Lin, Tao Yang, Jian Zhang, Peng Luo
Multimodal ChatGPT-4V for Electrocardiogram Interpretation: Promise and Limitations. Journal of medical Internet research 26 (2024)
Kexin Li, Hong Yang, Anqi Lin, Jiayi Xie, Haitao Wang, Jianguo Zhou, Shamus R Carr, Zaoqu Liu, Xiaohua Li, Jian Zhang, Quan Chen, David S Schrump, Peng Luo, Ting Wei
CPADS: a web tool for comprehensive pancancer analysis of drug sensitivity. Briefings in bioinformatics 25 (3) (2024)
Ronghui Liang, Zi-Wei Ye, Zhenzhi Qin, Yubin Xie, Xiaomeng Yang, Haoran Sun, Qiaohui Du, Peng Luo, Kaiming Tang, Bodan Hu, Jianli Cao, Xavier Hoi-Leong Wong, Guang-Sheng Ling, Hin Chu, Jiangang Shen, Feifei Yin, Dong-Yan Jin, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, Shuo-Feng Yuan
PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness. Nature communications 15 (1) (2024)
Lihaoyun Huang, Haitao Li, Cangang Zhang, Quan Chen, Zaoqu Liu, Jian Zhang, Peng Luo, Ting Wei
Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity. Clinical and translational medicine 14 (3) (2024)
Qi Yang, Xinyi Zhou, Jianbo Fang, Anqi Lin, Hongman Zhang, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan-cancer. Cancer science 115 (6) (2024)
Lingxuan Zhu, Weiming Mou, Keren Wu, Yancheng Lai, Anqi Lin, Tao Yang, Jian Zhang, Peng Luo
Multimodal ChatGPT-4V for Electrocardiogram Interpretation: Promise and Limitations. Journal of medical Internet research 26 (2024)
Qi Yang, Xinyi Zhou, Jianbo Fang, Anqi Lin, Hongman Zhang, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan-cancer. Cancer science 115 (6) (2024)
Kexin Li, Hong Yang, Anqi Lin, Jiayi Xie, Haitao Wang, Jianguo Zhou, Shamus R Carr, Zaoqu Liu, Xiaohua Li, Jian Zhang, Quan Chen, David S Schrump, Peng Luo, Ting Wei
CPADS: a web tool for comprehensive pancancer analysis of drug sensitivity. Briefings in bioinformatics 25 (3) (2024)
Kexin Li, Hong Yang, Anqi Lin, Jiayi Xie, Haitao Wang, Jianguo Zhou, Shamus R Carr, Zaoqu Liu, Xiaohua Li, Jian Zhang, Quan Chen, David S Schrump, Peng Luo, Ting Wei
CPADS: a web tool for comprehensive pancancer analysis of drug sensitivity. Briefings in bioinformatics 25 (3) (2024)
Lingxuan Zhu, Weiming Mou, Yancheng Lai, Junda Lin, Peng Luo
Language and cultural bias in AI: comparing the performance of large language models developed in different countries on Traditional Chinese Medicine highlights the need for localized models. Journal of translational medicine 22 (1) (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Hong Yang, Ying Shi, Anqi Lin, Chang Qi, Zaoqu Liu, Quan Cheng, Kai Miao, Jian Zhang, Peng Luo
PESSA: A web tool for pathway enrichment score-based survival analysis in cancer. PLoS computational biology 20 (5) (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Lingxuan Zhu, Weiming Mou, Keren Wu, Yancheng Lai, Anqi Lin, Tao Yang, Jian Zhang, Peng Luo
Multimodal ChatGPT-4V for Electrocardiogram Interpretation: Promise and Limitations. Journal of medical Internet research 26 (2024)
Lingxuan Zhu, Weiming Mou, Chenglin Hong, Tao Yang, Yancheng Lai, Chang Qi, Anqi Lin, Jian Zhang, Peng Luo
The Evaluation of Generative AI Should Include Repetition to Assess Stability. JMIR mHealth and uHealth 12 (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Yu Li, Cangang Zhang, Aimin Jiang, Anqi Lin, Zaoqu Liu, Xiangshu Cheng, Wanting Wang, Quan Cheng, Jian Zhang, Ting Wei, Peng Luo
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review. Journal of translational medicine 22 (1) (2024)
Yu Li, Cangang Zhang, Aimin Jiang, Anqi Lin, Zaoqu Liu, Xiangshu Cheng, Wanting Wang, Quan Cheng, Jian Zhang, Ting Wei, Peng Luo
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review. Journal of translational medicine 22 (1) (2024)
Yu Li, Cangang Zhang, Aimin Jiang, Anqi Lin, Zaoqu Liu, Xiangshu Cheng, Wanting Wang, Quan Cheng, Jian Zhang, Ting Wei, Peng Luo
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review. Journal of translational medicine 22 (1) (2024)
Lingxuan Zhu, Weiming Mou, Yancheng Lai, Junda Lin, Peng Luo
Language and cultural bias in AI: comparing the performance of large language models developed in different countries on Traditional Chinese Medicine highlights the need for localized models. Journal of translational medicine 22 (1) (2024)
Lingxuan Zhu, Weiming Mou, Chenglin Hong, Tao Yang, Yancheng Lai, Chang Qi, Anqi Lin, Jian Zhang, Peng Luo
The Evaluation of Generative AI Should Include Repetition to Assess Stability. JMIR mHealth and uHealth 12 (2024)
Ronghui Liang, Zi-Wei Ye, Zhenzhi Qin, Yubin Xie, Xiaomeng Yang, Haoran Sun, Qiaohui Du, Peng Luo, Kaiming Tang, Bodan Hu, Jianli Cao, Xavier Hoi-Leong Wong, Guang-Sheng Ling, Hin Chu, Jiangang Shen, Feifei Yin, Dong-Yan Jin, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, Shuo-Feng Yuan
PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness. Nature communications 15 (1) (2024)
Qin Dang, Lulu Zuo, Xinru Hu, Zhaokai Zhou, Shuang Chen, Shutong Liu, Yuhao Ba, Anning Zuo, Hui Xu, Siyuan Weng, Yuyuan Zhang, Peng Luo, Quan Chen, Zaoqu Liu, Xin-Wei Han
Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges. Cancer medicine 13 (14) (2024)
Yu Li, Cangang Zhang, Aimin Jiang, Anqi Lin, Zaoqu Liu, Xiangshu Cheng, Wanting Wang, Quan Cheng, Jian Zhang, Ting Wei, Peng Luo
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review. Journal of translational medicine 22 (1) (2024)
Yu Li, Cangang Zhang, Aimin Jiang, Anqi Lin, Zaoqu Liu, Xiangshu Cheng, Wanting Wang, Quan Cheng, Jian Zhang, Ting Wei, Peng Luo
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review. Journal of translational medicine 22 (1) (2024)
Kexin Li, Hong Yang, Anqi Lin, Jiayi Xie, Haitao Wang, Jianguo Zhou, Shamus R Carr, Zaoqu Liu, Xiaohua Li, Jian Zhang, Quan Chen, David S Schrump, Peng Luo, Ting Wei
CPADS: a web tool for comprehensive pancancer analysis of drug sensitivity. Briefings in bioinformatics 25 (3) (2024)
Zizhuo Li, Anqi Lin, Zhifei Gao, Aimin Jiang, Minying Xiong, Jiapeng Song, Zaoqu Liu, Quan Chen, Jian Zhang, Peng Luo
B-cell performance in chemotherapy: Unravelling the mystery of B-cell therapeutic potential. Clinical and translational medicine 14 (7) (2024)
Hong Yang, Ying Shi, Anqi Lin, Chang Qi, Zaoqu Liu, Quan Cheng, Kai Miao, Jian Zhang, Peng Luo
PESSA: A web tool for pathway enrichment score-based survival analysis in cancer. PLoS computational biology 20 (5) (2024)
Qin Dang, Lulu Zuo, Xinru Hu, Zhaokai Zhou, Shuang Chen, Shutong Liu, Yuhao Ba, Anning Zuo, Hui Xu, Siyuan Weng, Yuyuan Zhang, Peng Luo, Quan Chen, Zaoqu Liu, Xin-Wei Han
Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges. Cancer medicine 13 (14) (2024)
Lingxuan Zhu, Weiming Mou, Keren Wu, Yancheng Lai, Anqi Lin, Tao Yang, Jian Zhang, Peng Luo
Multimodal ChatGPT-4V for Electrocardiogram Interpretation: Promise and Limitations. Journal of medical Internet research 26 (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung-Hung Luo, Markus Hecht, Benjamin Frey, Udo S Gaipl, Xue-Jun Li, Qi Zhao, Hu Ma, Jian-Guo Zhou
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for immunotherapy of cancer 12 (1) (2024)
Lingxuan Zhu, Weiming Mou, Yancheng Lai, Junda Lin, Peng Luo
Language and cultural bias in AI: comparing the performance of large language models developed in different countries on Traditional Chinese Medicine highlights the need for localized models. Journal of translational medicine 22 (1) (2024)
Zizhuo Li, Anqi Lin, Zhifei Gao, Aimin Jiang, Minying Xiong, Jiapeng Song, Zaoqu Liu, Quan Chen, Jian Zhang, Peng Luo
B-cell performance in chemotherapy: Unravelling the mystery of B-cell therapeutic potential. Clinical and translational medicine 14 (7) (2024)
Lihaoyun Huang, Haitao Li, Cangang Zhang, Quan Chen, Zaoqu Liu, Jian Zhang, Peng Luo, Ting Wei
Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity. Clinical and translational medicine 14 (3) (2024)
Lingxuan Zhu, Haoran Zhang, Peng Luo
The Potential of Using ChatGPT-4 Vision for Detecting Image Manipulation in Academic Medicine Articles. Academic medicine : journal of the Association of American Medical Colleges (2024)
Tianqi Gu, Anqi Lin, Haitao Wang, Jian Zhang, Peng Luo
Reply to: Comments on "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis". International journal of cancer (2023)
Aimin Jiang, Chen Cai, Yiren Yang, Yankang Cui, Wenqiang Liu, Qingyang Pang, Zhenjie Wu, Bing Liu, Le Qu, Peng Luo, Anbang Wang, Linhui Wang
Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Anqi Lin, Jiarong Yao, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. Journal of inflammation research 16 (2023)
Anqi Lin, Weiming Mou, Lingxuan Zhu, Tao Yang, Chaozheng Zhou, Jian Zhang, Peng Luo
Mutations in the DNA polymerase binding pathway affect the immune microenvironment of patients with small-cell lung cancer and enhance the efficacy of platinum-based chemotherapy. Cancer innovation 2 (6) (2023)
Aimin Jiang, Chen Cai, Yiren Yang, Yankang Cui, Wenqiang Liu, Qingyang Pang, Zhenjie Wu, Bing Liu, Le Qu, Peng Luo, Anbang Wang, Linhui Wang
Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Anqi Lin, Jiarong Yao, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. Journal of inflammation research 16 (2023)
Yushan Huang, Anqi Lin, Tianqi Gu, Shuang Hou, Jiarong Yao, Peng Luo, Jian Zhang
CACNA1C mutation as a prognosis predictor of immune checkpoint inhibitor in skin cutaneous melanoma. Immunotherapy (2023)
Chunrun Qu, Sheng Liao, Jingdan Zhang, Hui Cao, Hao Zhang, Nan Zhang, Luzhe Yan, Gaoyuan Cui, Peng Luo, Qingwei Zhang, Quan Chen
Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019. European heart journal. Quality of care & clinical outcomes (2023)
Zeyu Wang, Ziyu Dai, Hao Zhang, Nan Zhang, Xisong Liang, Peng Luo, Jian Zhang, Zaoqu Liu, Yun Peng, Quan Chen, Zhixiong Liu
Comprehensive analysis of pyroptosis-related gene signatures for glioblastoma immune microenvironment and target therapy. Cell proliferation 56 (3) (2023)
Zeyu Wang, Ziyu Dai, Hao Zhang, Nan Zhang, Xisong Liang, Peng Luo, Jian Zhang, Zaoqu Liu, Yun Peng, Quan Chen, Zhixiong Liu
Comprehensive analysis of pyroptosis-related gene signatures for glioblastoma immune microenvironment and target therapy. Cell proliferation 56 (3) (2023)
Tianqi Gu, Anqi Lin, Haitao Wang, Jian Zhang, Peng Luo
Reply to: Comments on "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis". International journal of cancer (2023)
Aimin Jiang, Chen Cai, Yiren Yang, Yankang Cui, Wenqiang Liu, Qingyang Pang, Zhenjie Wu, Bing Liu, Le Qu, Peng Luo, Anbang Wang, Linhui Wang
Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Zeyu Wang, Ziyu Dai, Hao Zhang, Nan Zhang, Xisong Liang, Peng Luo, Jian Zhang, Zaoqu Liu, Yun Peng, Quan Chen, Zhixiong Liu
Comprehensive analysis of pyroptosis-related gene signatures for glioblastoma immune microenvironment and target therapy. Cell proliferation (2023)
Anqi Lin, Jiarong Yao, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. Journal of inflammation research 16 (2023)
Liying Liu, Yanan Xie, Hong Yang, Anqi Lin, Minjun Dong, Haitao Wang, Cangang Zhang, Zaoqu Liu, Quan Chen, Jian Zhang, Shuofeng Yuan, Peng Luo
HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus-associated cancers. iMeta 2 (3) (2023)
Anqi Lin, Jiarong Yao, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. Journal of inflammation research 16 (2023)
Anqi Lin, Weiming Mou, Lingxuan Zhu, Tao Yang, Chaozheng Zhou, Jian Zhang, Peng Luo
Mutations in the DNA polymerase binding pathway affect the immune microenvironment of patients with small-cell lung cancer and enhance the efficacy of platinum-based chemotherapy. Cancer innovation 2 (6) (2023)
Xinyu Wang, Meiyuan Zeng, Xueming Ju, Anqi Lin, Chaozheng Zhou, Junyi Shen, Zaoqu Liu, Bufu Tang, Quan Chen, Youyu Wang, Jian Zhang, Peng Luo
Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients. The British journal of surgery (2023)
Zeyu Wang, Ziyu Dai, Hao Zhang, Nan Zhang, Xisong Liang, Peng Luo, Jian Zhang, Zaoqu Liu, Yun Peng, Quan Chen, Zhixiong Liu
Comprehensive analysis of pyroptosis-related gene signatures for glioblastoma immune microenvironment and target therapy. Cell proliferation 56 (3) (2023)
Nan Zhang, Hao Zhang, Zaoqu Liu, Ziyu Dai, Wantao Wu, Ran Zhou, Shuyu Li, Zeyu Wang, Xisong Liang, Jie Wen, Xun Zhang, Bo Zhang, Sirui Ouyang, Jian Zhang, Peng Luo, Xizhe Li, Quan Chen
An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms. Cell proliferation (2023)
Liying Liu, Yanan Xie, Hong Yang, Anqi Lin, Minjun Dong, Haitao Wang, Cangang Zhang, Zaoqu Liu, Quan Chen, Jian Zhang, Shuofeng Yuan, Peng Luo
HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus-associated cancers. iMeta 2 (3) (2023)
Congqi Shi, Kaiyu Qin, Anqi Lin, Aimin Jiang, Quan Cheng, Zaoqu Liu, Jian Zhang, Peng Luo
The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Zifu Yao, Anqi Lin, Yonglin Yi, Weitao Shen, Jian Zhang, Peng Luo
THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients. Drug design, development and therapy 16 (2022)
Anqi Lin, Lingxuan Zhu, Aimin Jiang, Weiming Mou, Jian Zhang, Peng Luo
Activation of the TGF- β Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients. Disease markers 2022 (2022)
Wen-Jing Zeng, Yu-Fang Cao, He Li, Zhi-Cheng Gong, Wantao Wu, Peng Luo, Jian Zhang, Zaoqu Liu, Hao Zhang, Quan Chen
A Novel Thrombosis-Related Signature for Predicting Survival and Drug Compounds in Glioblastoma. Journal of oncology 2022 (2022)
Anqi Lin, Tianqi Gu, Xigang Hu, Jian Zhang, Peng Luo
Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment. Journal of immunology research 2022 (2022)
Xisong Liang, Zeyu Wang, Ziyu Dai, Hao Zhang, Jian Zhang, Peng Luo, Zaoqu Liu, Zhixiong Liu, Kui Yang, Quan Chen, Mingyu Zhang
Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy. Cancer gene therapy 30 (3) (2022)
Xisong Liang, Zeyu Wang, Ziyu Dai, Hao Zhang, Jian Zhang, Peng Luo, Zaoqu Liu, Zhixiong Liu, Kui Yang, Quan Chen, Mingyu Zhang
Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy. Cancer gene therapy (2022)
Xisong Liang, Zeyu Wang, Ziyu Dai, Hao Zhang, Jian Zhang, Peng Luo, Zaoqu Liu, Zhixiong Liu, Kui Yang, Quan Chen, Mingyu Zhang
Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy. Cancer gene therapy 30 (3) (2022)
Xisong Liang, Zeyu Wang, Ziyu Dai, Hao Zhang, Jian Zhang, Peng Luo, Zaoqu Liu, Zhixiong Liu, Kui Yang, Quan Chen, Mingyu Zhang
Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy. Cancer gene therapy 30 (3) (2022)
Anqi Lin, Chang Qi, Ting Wei, Mengyao Li, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Briefings in bioinformatics 23 (3) (2022)
Hao Zhang, Nan Zhang, Ziyu Dai, Zeyu Wang, Xun Zhang, Xisong Liang, Liyang Zhang, Songshan Feng, Wantao Wu, Weijie Ye, Jian Zhang, Peng Luo, Zaoqu Liu, Quan Chen, Zhixiong Liu
Hyaluronic acids mediate the infiltration, migration, and M2 polarization of macrophages: evaluating metabolic molecular phenotypes in gliomas. Molecular oncology 16 (22) (2022)
Tianqi Gu, Aimin Jiang, Chaozheng Zhou, Anqi Lin, Quan Chen, Zaoqu Liu, Jian Zhang, Peng Luo
Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis. International journal of cancer (2022)
Chufeng Chen, Jiaying Liu, Yidong Chen, Anqi Lin, Weiming Mou, Lingxuan Zhu, Tao Yang, Quan Cheng, Jian Zhang, Peng Luo
Application of ATAC-seq in tumor-specific T cell exhaustion. Cancer gene therapy (2022)
Zicheng Wang, Xisong Liang, Hao Zhang, Zeyu Wang, Xun Zhang, Ziyu Dai, Zaoqu Liu, Jian Zhang, Peng Luo, Jiarong Li, Quan Chen
Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer. Journal of immunology research 2022 (2022)
Hao Zhang, Nan Zhang, Wantao Wu, Ran Zhou, Shuyu Li, Zeyu Wang, Ziyu Dai, Liyang Zhang, Zaoqu Liu, Jian Zhang, Peng Luo, Zhixiong Liu, Quan Chen
Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma. Briefings in bioinformatics 23 (6) (2022)
Anqi Lin, Lingxuan Zhu, Aimin Jiang, Weiming Mou, Jian Zhang, Peng Luo
Activation of the TGF- β Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients. Disease markers 2022 (2022)
Anqi Lin, Jianbo Fang, Quan Chen, Zaoqu Liu, Peng Luo, Jian Zhang
B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis. Journal of inflammation research 15 (2022)
Qiong Lyu, Weiliang Zhu, Ting Wei, Weimin Ding, Manming Cao, Qiongyao Wang, Linlang Guo, Peng Luo, Jian Zhang
High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy. Cancer medicine 10 (21) (2021)
Qiong Lyu, Anqi Lin, Manming Cao, Abai Xu, Peng Luo, Jian Zhang
Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition. Cancer control : journal of the Moffitt Cancer Center 27 (1) (2021)
Yanan Gao, Qiong Lyu, Peng Luo, Mujiao Li, Rui Zhou, Jian Zhang, Qingwen Lyu
Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer. International journal of general medicine 14 (2021)
Yimin Li, Yonglin Yi, Anqi Lin, Peng Luo, Jian Zhang
A comparison of the efficacy of antiangiogenic agents combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis. Cancer cell international 20 (1) (2020)
Lilan Yi, Junsheng Fan, Ruolan Qian, Peng Luo, Jian Zhang
Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: A meta-analysis. International journal of cancer 145 (1) (2019)
Lilan Yi, Peng Luo, Jian Zhang
Author's Reply to: Osimertinib and jaw osteonecrosis? A case report. International journal of cancer 145 (7) (2019)
Jingwen Zou, Weiliang Zhu, Hui Meng, Peng Luo, Jian Zhang
Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis. Expert review of gastroenterology & hepatology 13 (3) (2019)
Lilan Yi, Peng Luo, Jian Zhang
Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis. Journal of cellular biochemistry 120 (9) (2019)
Junsheng Fan, Tszhei Fong, Zengfei Xia, Jian Zhang, Peng Luo
The efficacy and safety of ALK inhibitors in the treatment of ALK-positive non-small cell lung cancer: A network meta-analysis. Cancer medicine 7 (10) (2018)